Is QUALIOST Appropriate for the Patients With Orthotopic Liver Transplantation in Measuring Quality of Life?

Basit Öğe Kaydı
dc.contributor.authorAtamaz, F.
dc.contributor.authorHepguler, S.
dc.contributor.authorOzturk, C.
dc.contributor.authorPinar, Y.
dc.date.accessioned2019-10-27T21:55:00Z
dc.date.available2019-10-27T21:55:00Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstractThe quality of life questionnaire in osteoporosis (QUALIOST) measures the impact of this condition. The purpose of this study was to assess the psychometric properties of QUALIOST among 38 orthotopic liver transplantation (OLT) patients who had been diagnosed with osteoporosis or osteopenia versus 42 control subjects with osteoporosis or osteopenia associated with other conditions. Bone mineral density (gr/cm(2)) measurements were performed by dual-energy X-ray absorptiometry as well as thoracic and lumbar spine radiographs to assess fractures. Reliability studies evaluated by intraclass correlation coefficients (ICC) and internal consistency (Cronbach alpha). For the validity studies, correlation analysis was performed between this scale and Short Form-36 (SF-36) results. The questionnaire was filled out completely by all the patients with 0.9% and 1.3% of omitted answer rates for OLT and control patients. ICC and Cronbach's alpha values were good for all domains with values above .90. In both groups we observed significant negative high correlations between the domains of the questionnaire and all SF-36 dimensions (P < .001). At least one vertebral fracture was diagnosed in 17 (44.7%) and 20 (47.6%) patients with OLT and control respectively. The comparison analysis revealed that the scores of QUALIOST of patients with vertebral fracture were significantly higher than those without a fracture in both groups (P < .05). In conclusion, we evaluated the validity and reliability of a scale measuring quality of life in patients who had osteoporosis secondary to OLT. The results showed that the Turkish QUALIOST showed acceptable validity and reliability in these patients.en_US
dc.identifier.doi10.1016/j.transproceed.2012.10.027en_US
dc.identifier.endpage289en_US
dc.identifier.issn0041-1345
dc.identifier.issn1873-2623
dc.identifier.issue1en_US
dc.identifier.pmid23375317en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage286en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2012.10.027
dc.identifier.urihttps://hdl.handle.net/11454/48169
dc.identifier.volume45en_US
dc.identifier.wosWOS:000315007200056en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleIs QUALIOST Appropriate for the Patients With Orthotopic Liver Transplantation in Measuring Quality of Life?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu